Loading…
STERIS plc is projected to rise to $267.61 by 2027, a +26% move from its current price of $212.87. STE is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $209.99 | $212.92 | $215.89 | +0.02% |
| May 30 | $208.83 | $212.97 | $217.18 | +0.05% |
| May 31 | $207.96 | $213.01 | $218.19 | +0.07% |
| Jun 1 | $207.24 | $213.06 | $219.05 | +0.09% |
| Jun 2 | $206.61 | $213.11 | $219.82 | +0.11% |
| Jun 3 | $206.04 | $213.16 | $220.52 | +0.14% |
| Jun 4 | $205.53 | $213.21 | $221.17 | +0.16% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $205.53 | $213.21 | $221.17 | +0.16% |
| Week 2 | $202.75 | $213.54 | $224.91 | +0.32% |
| Week 3 | $200.72 | $213.88 | $227.90 | +0.47% |
| Week 4 | $199.07 | $214.22 | $230.52 | +0.63% |
| Week 5 | $197.66 | $214.55 | $232.89 | +0.79% |
| Week 6 | $196.43 | $214.89 | $235.09 | +0.95% |
| Week 7 | $195.33 | $215.23 | $237.16 | +1.11% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. It also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services.
It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.
STERIS plc is a healthcare company traded under the symbol STE. It has a market cap of $21.26B and is ranked 572 in the provided dataset. The current price is $216.57. The stock is positioned for a developed price path with a clear long-term forecast across multiple years.
A major floor 11.1% below — a decisive break under it would weaken the trend.
The nearest floor, 5.2% below — buyers have tended to step in here.
The nearest ceiling, 6.4% above — a clean break opens room to run.
A major ceiling 26.2% above — clearing it would confirm fresh momentum.
Key STE support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of STE market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $216.27 | Sell | $215.07 | Sell |
| MA 10 | $214.78 | Sell | $214.75 | Sell |
| MA 20 | $213.26 | Sell | $215.14 | Sell |
| MA 50 | $218.24 | Sell | $220.34 | Sell |
| MA 100 | $234.10 | Sell | $228.49 | Sell |
| MA 200 | $241.87 | Sell | $234.18 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 45.64 | Neutral |
| Stoch RSI (14) | 65.71 | Neutral |
| CCI (20) | -10.24 | Neutral |
| Williams %R (14) | -38.16 | Info |
| MACD (12,26,9) | 0.80 | Buy |
| ROC (12) | 2.61 | Buy |
| Bollinger %B (20,2) | 0.47 | Neutral |
| Stochastic %K (14) | 61.84 | Neutral |
| TRIX (15) | -0.13 | Sell |
| Awesome (5,34) | -0.94 | Sell |
| Ultimate (7,14,28) | 50.41 | Neutral |
| Momentum (10) | 2.02 | Buy |
| Aroon Osc (25) | -52.00 | Sell |
| Hull MA (9) | 216.75 | Sell |
| ADX (14) | 12.08 | Neutral |
| ATR (14) | 2.80 | Info |
Technically, the near term shows a neutral stance. The RSI14 is 50, and the stock trades around the 50-day moving average near $218.33, with the 200-day moving average near $242.12.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $201.85 | $212.87 | $291.05 | 0% | Neutral | |
| $218.62 | $267.61 | $342.88 | +26% | Bullish | |
| $244.45 | $304.69 | $400.60 | +43% | Bullish | |
| $255.09 | $322.77 | $433.19 | +52% | Bullish | |
| $246.05 | $315.48 | $430.91 | +48% | Bullish | |
| $268.84 | $348.86 | $483.93 | +64% | Bullish | |
| $289.98 | $380.50 | $535.24 | +79% | Bullish | |
| $318.53 | $422.35 | $601.71 | +98% | Bullish | |
| $360.88 | $483.23 | $696.60 | +127% | Bullish | |
| $372.53 | $503.52 | $733.87 | +137% | Bullish | |
| $515.84 | $727.06 | $1,110.16 | +242% | Bullish | |
| $798.99 | $1,207.61 | $1,975.97 | +467% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $201.85 | $212.87 | $249.29 | +0.00% |
| June 2026 | $182.53 | $212.93 | $253.21 | +0.03% |
| July 2026 | $185.20 | $217.29 | $260.84 | +2.05% |
| August 2026 | $190.96 | $225.06 | $272.13 | +3.58% |
| September 2026 | $190.44 | $225.28 | $274.02 | +0.10% |
| October 2026 | $188.33 | $223.54 | $273.37 | -0.77% |
| November 2026 | $192.86 | $229.61 | $282.11 | +2.72% |
| December 2026 | $197.52 | $235.83 | $291.05 | +2.71% |
Click any year to see its month-by-month STE forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, STE is projected to trade between $201.85 and $291.05, averaging $212.87 — a potential gain of 0% from today's $212.87. A consolidation phase looks the most probable path here.
STERIS plc's 2027 outlook centres on $267.61, within a $218.62 to $342.88 range. That is up +26% on the projected 2026 average. That marks a +26% change versus current levels. Momentum favours further upside here.
By 2028, STE could reach as high as $400.60, with a base case around $304.69 and support toward $244.45 — roughly +43% from $212.87. Buyers look set to stay in control over this stretch.
Expect STE to range from $255.09 to $433.19 through 2029. The $322.77 average target implies a +52% move from current prices. That is up +6% on the projected 2028 average. Momentum favours further upside here.
The STE price prediction for 2030 points to an average of $315.48 (low $246.05, high $430.91) — a potential gain of +48% on today's $212.87. Buyers look set to stay in control over this stretch.
In 2031, STE is projected to trade between $268.84 and $483.93, averaging $348.86 — a potential gain of +64% from today's $212.87. That is up +11% on the projected 2030 average. Momentum favours further upside here.
STERIS plc's 2032 outlook centres on $380.50, within a $289.98 to $535.24 range. That is up +9% on the projected 2031 average. That marks a +79% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, STE could reach as high as $601.71, with a base case around $422.35 and support toward $318.53 — roughly +98% from $212.87. Momentum favours further upside here.
Expect STE to range from $360.88 to $696.60 through 2034. The $483.23 average target implies a +127% move from current prices. That is up +14% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The STE price prediction for 2035 points to an average of $503.52 (low $372.53, high $733.87) — a potential gain of +137% on today's $212.87. Momentum favours further upside here.
In 2040, STE is projected to trade between $515.84 and $1,110.16, averaging $727.06 — a potential gain of +242% from today's $212.87. That is up +44% on the projected 2035 average. Buyers look set to stay in control over this stretch.
STERIS plc's 2050 outlook centres on $1,207.61, within a $798.99 to $1,975.97 range. That is up +66% on the projected 2040 average. That marks a +467% change versus current levels. Momentum favours further upside here.
Investing $1,000 in STE today (≈ 4.697703 STE) could be worth
$5,672.99
+$4,672.99 (+467%) by 2050 · US Dollar
Based on the average projected STE price of $1,207.61 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in STEwould be worth at today's price.
$1,000 invested in STE on May 27, 2025 (≈ 4.061738 STE) would be worth
$864.62
-$135.38 (-13.5%) today · 0.86× · US Dollar
Based on a STE entry price of $246.2 vs. today's $212.87.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $215.97 | $985.65 | -1.4% |
| 1 month ago | $222.19 | $958.05 | -4.2% |
| 3 months ago | $254.7 | $835.77 | -16.4% |
| 6 months ago | $266.28 | $799.42 | -20.1% |
| 1 year ago | $246.2 | $864.62 | -13.5% |
| All time (5.0y) ago | $188.43 | $1,129.7 | +13.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our STE forecast.
Our base-case forecast reaches $430.00 around 2034.
Implied market cap at $430.00: $42.17B
The multi-year forecast shows bullish sentiment from 2027 onward with rising averages and ROIs. In 2027 the average is $276.12 with ROI 27.5 and bullish sentiment; in 2028 the average is $315.96 with ROI 45.9; in 2029 the average is $334.56 with ROI 54.5; in 2030 the average is $328.75 with ROI 51.8 and bullish sentiment. The long-range view strengthens further with 2040 where the average is $786.52 and ROI 263.2, and 2050 where the average is $1,307.86 and ROI 503.9, both bullish.
These figures illustrate meaningful upside over the coming years, but they are estimates and not guarantees. The forecast also shows sustained bullish momentum across the 2031–2035 window (e.g., 2031 avg $368.04, ROI 69.9; 2032 avg $401.90, ROI 85.6; 2033 avg $447.28, ROI 106.5; 2034 avg $515.40, ROI 138; 2035 avg $535.20, ROI 147.1).
Tap a question to reveal the answer.
min $256.35, avg $328.75, max $449.14; ROI 51.8; sentiment BULLISH.
The forecast shows bullish sentiment across multiple years, with rising averages and ROIs such as 27.5% in 2027, 45.9% in 2028, 54.5% in 2029, 51.8% in 2030, 263.2% in 2040, and 503.9% in 2050, indicating upside potential while noting these are estimates, not guarantees.
Yes. For 2028, the average is $315.96 with a max of $415.56, which crosses $300; 2029 and 2030 also show averages above $300 (334.56 and 328.75 respectively), indicating the path moves past $300 in the forecast window.
Current price is $216.57. The 30-day range is $197.01 to $238.07.
RSI14 is 50; SMA50 is $218.33; SMA200 is $242.12. The 30-day support is $201.85 and resistance is $226.41; the 30-day range is $197.01 to $238.07; sentiment is NEUTRAL and annualized volatility is 30%.
STERIS plc Community Discussion
0Share your STERIS plc price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.